semaglutide patent protection Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite With semaglutide's patent expiring, generics

The authors concluded that the observed increase in drug exposure is not clinically significant and likely does not require dose adjustment

1 If contemplating a switch from semaglutide to tirzepatide, understanding the differences, potential benefits, and practical steps involved is crucial for making an informed decision in partnership with a healthcare provider

For semaglutide users who also use creatine alongside GLP-1 medications , combining creatine with your post-workout protein shake is a convenient way to get both supplements in one serving

Provider consultations A Google Meet video consultation is required before prescribing

These lifestyle modifications can help support long-term weight maintenance and prevent the return of lost weight